Triamterene nephrolithiasis: renewed attention is warranted.
Although triamterene has been known to contribute to urinary calculus formation, it has been presumed to be a rare phenomenon. Our review of stone analyses performed during the last decade by a single laboratory reveals an increasing incidence of triamterene stones. Awareness of the calculogenic potential of triamterene-containing medications should be re-emphasized.
Carr
M C
MC
Department of Urology, Boston University Medical Center, Massachusetts.
Prien
E L
EL
Babayan
R K
RK
D006801:Humans; D015994:Incidence; D007669:Kidney Calculi / Q000139:chemically induced* / Q000737:chemistry / Q000453:epidemiology; D008404:Massachusetts / Q000453:epidemiology; D014223:Triamterene / Q000009:adverse effects* / Q000032:analysis / Q000627:therapeutic use
D014223:Triamterene